Cellectar Biosciences (CLRB) Revenue & Revenue Breakdown
Cellectar Biosciences Revenue Highlights
00
Cellectar Biosciences Revenue by Period
Cellectar Biosciences Revenue by Year
Date | Revenue | Change |
---|---|---|
2023-12-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2012-12-31 | - | -100.00% |
2011-12-31 | $-11.00K | -133.00% |
2010-12-31 | $33.33K | -65.39% |
2009-12-31 | $96.31K | -23.54% |
2008-12-31 | $125.97K | 100.00% |
2007-12-31 | - | 100.00% |
2006-12-31 | - | -100.00% |
2005-12-31 | $12.58K | - |
Cellectar Biosciences Revenue by Quarter
Date | Revenue | Change |
---|---|---|
2024-09-30 | - | 100.00% |
2024-06-30 | - | 100.00% |
2024-03-31 | - | -100.00% |
2023-12-31 | $330.37K | 100.00% |
2023-09-30 | - | 100.00% |
2023-06-30 | - | 100.00% |
2023-03-31 | - | 100.00% |
2022-12-31 | - | 100.00% |
2022-09-30 | - | 100.00% |
2022-06-30 | - | 100.00% |
2022-03-31 | - | 100.00% |
2021-12-31 | - | 100.00% |
2021-09-30 | - | 100.00% |
2021-06-30 | - | 100.00% |
2021-03-31 | - | 100.00% |
2020-12-31 | - | 100.00% |
2020-09-30 | - | 100.00% |
2020-06-30 | - | 100.00% |
2020-03-31 | - | 100.00% |
2019-12-31 | - | 100.00% |
2019-09-30 | - | 100.00% |
2019-06-30 | - | 100.00% |
2019-03-31 | - | 100.00% |
2018-12-31 | - | 100.00% |
2018-09-30 | - | 100.00% |
2018-06-30 | - | 100.00% |
2018-03-31 | - | 100.00% |
2017-12-31 | - | 100.00% |
2017-09-30 | - | 100.00% |
2017-06-30 | - | 100.00% |
2017-03-31 | - | 100.00% |
2016-12-31 | - | 100.00% |
2016-09-30 | - | 100.00% |
2016-06-30 | - | 100.00% |
2016-03-31 | - | 100.00% |
2015-12-31 | - | 100.00% |
2015-09-30 | - | 100.00% |
2015-06-30 | - | 100.00% |
2015-03-31 | - | 100.00% |
2014-12-31 | - | 100.00% |
2014-09-30 | - | 100.00% |
2014-06-30 | - | 100.00% |
2014-03-31 | - | 100.00% |
2013-12-31 | - | 100.00% |
2013-09-30 | - | 100.00% |
2013-06-30 | - | 100.00% |
2013-03-31 | - | 100.00% |
2012-12-31 | - | 100.00% |
2012-09-30 | - | 100.00% |
2012-06-30 | - | 100.00% |
2012-03-31 | - | 100.00% |
2011-12-31 | - | 100.00% |
2011-09-30 | - | 100.00% |
2011-06-30 | - | -100.00% |
2011-03-31 | $8.33K | -0.01% |
2010-12-31 | $8.33K | 0.01% |
2010-09-30 | $8.33K | - |
2010-06-30 | $8.33K | - |
2010-03-31 | $8.33K | -56.89% |
2009-12-31 | $19.33K | 41.08% |
2009-09-30 | $13.70K | -57.60% |
2009-06-30 | $32.31K | 4.34% |
2009-03-31 | $30.97K | -15.03% |
2008-12-31 | $36.45K | 2.62% |
2008-09-30 | $35.51K | -22.25% |
2008-06-30 | $45.68K | 448.13% |
2008-03-31 | $8.33K | 100.00% |
2007-12-31 | - | - |
Cellectar Biosciences Peer Comparison by Revenue
Ticker | Company | Last Year Revenue | Last Quarter Revenue |
---|---|---|---|
CAPR | Capricor Therapeutics | $25.18M | $2.26B |
BOLT | Bolt Biotherapeutics | $7.88M | $1.14M |
PULM | Pulmatrix | $7.30M | $366.00K |
LUMO | Lumos Pharma | $2.05M | $488.00K |
CBIO | Gyre Therapeutics | $794.00K | - |
BPTH | Bio-Path | - | - |
LBPH | Longboard Pharmaceuticals | - | - |
NXTC | NextCure | - | - |
BNTC | Benitec Biopharma | - | - |
ALRN | Aileron Therapeutics | - | - |
CLRB | Cellectar Biosciences | - | - |
MNPR | Monopar Therapeutics | - | - |
TENX | Tenax Therapeutics | - | - |
DFFN | CervoMed | - | - |